How Does Treclin Work in the Body
Chemical Composition, Mechanism of Action & Metabolic Effects Explained
Key Takeaways: How Treclin Works
- Active Ingredients: Clindamycin 1% (antibiotic) and tretinoin 0.025% (retinoid).
- Dual Mechanism: Clindamycin inhibits Cutibacterium acnes protein synthesis; tretinoin normalises follicular keratinocyte shedding.
- Synergy: The combination reduces both bacterial load and microcomedone formation, leading to improved inflammatory and non‑inflammatory lesion clearance.
- Pharmacokinetics: Minimal systemic absorption (both agents <2% of applied dose) – action is predominantly localised to the skin.
- Onset & Duration: Initial improvement often seen by 4–6 weeks; optimal results after 8–12 weeks of nightly use.
Treclin Gel combines the antibiotic clindamycin with the retinoid tretinoin to tackle acne from two angles: suppressing acne‑causing bacteria and preventing clogged pores. This dual‑action approach delivers superior efficacy compared to either component alone.
Important Safety Information
Do not use Treclin if you are pregnant, planning pregnancy, or have inflammatory bowel disease, a history of antibiotic‑associated colitis, rosacea, or eczema. Avoid sun exposure – use SPF 30+ sunscreen. If you experience severe diarrhoea or abdominal cramps, stop use immediately and consult your doctor. Avoid contact with eyes, mouth, and broken skin.
Chemical Composition & Molecular Structure
Treclin gel contains two active pharmaceutical ingredients: clindamycin (as clindamycin phosphate) at 1% w/w (10 mg/g) and tretinoin at 0.025% w/w (0.25 mg/g). The formulation uses a translucent, water‑based gel that enhances skin penetration and minimises irritation.
Structural Details
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside 2-(dihydrogen phosphate)
A semi‑synthetic lincosamide antibiotic. The phosphate ester improves stability and is rapidly hydrolysed in vivo to active clindamycin. Its structure targets the bacterial 50S ribosomal subunit.
3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
A naturally occurring retinoid derived from vitamin A. It binds with high affinity to retinoic acid receptors (RAR‑γ) in the skin, regulating gene transcription involved in epithelial differentiation.
Key Pharmaceutical Properties
| Property | Clindamycin (active) | Tretinoin |
|---|---|---|
| Molecular weight | 425 g/mol (base) | 300.4 g/mol |
| Log P (lipophilicity) | 2.1 | 6.4 (highly lipophilic) |
| Protein binding | ~94% (systemic) | >95% (plasma, negligible after topical) |
| pKa | 7.6 (basic) | 4.2 (carboxylic acid) |
🗒️ Formulation insight: The gel base contains glycerol, carbomers, methylparahydroxybenzoate, propylparahydroxybenzoate, and butylhydroxytoluene (E321) – these preserve the product and provide a cosmetically acceptable vehicle that dries quickly without excessive oiliness.
Mechanism of Action: Dual Pathway of Clindamycin and Tretinoin
Acne vulgaris involves four key factors: excess sebum, follicular hyperkeratinisation, colonisation by Cutibacterium acnes, and inflammation. Treclin targets two of these directly while indirectly affecting the others.
- Clindamycin – Antibacterial & Anti‑inflammatory: Clindamycin enters bacterial cells and binds reversibly to the 50S ribosomal subunit, inhibiting peptide chain elongation. This bacteriostatic effect reduces C. acnes populations and subsequently decreases the release of pro‑inflammatory chemotactic factors (e.g., lipases, proteases).
- Tretinoin – Comedolytic & Keratinocyte Normalisation: Tretinoin binds to nuclear retinoic acid receptors (RAR-α, RAR-γ) in follicular keratinocytes. This activates transcription of genes that promote desquamation and reduce keratinocyte adhesion. The result is loosening of microcomedones, preventing the formation of both open and closed comedones.
- Synergistic effect: By simultaneously reducing bacterial load and normalising follicular shedding, the combination prevents new lesions and accelerates resolution of existing inflammatory lesions. Clinical studies show greater reduction in total lesion count compared to either monotherapy.
| Action | Clindamycin | Tretinoin |
|---|---|---|
| Primary target | C. acnes ribosome | Follicular keratinocyte RARs |
| Onset of effect | 2–4 weeks (inflammatory lesions) | 2–3 weeks (initial retinoid reaction, full effect 8–12 weeks) |
| Key clinical outcome | Reduction in papules/pustules | Reduction in comedones, improved skin texture |
🗒️ Clinical insight: The combination also exhibits mild anti‑inflammatory activity independent of antibacterial effects, making it effective against non‑inflammatory comedones and inflammatory lesions alike.
Absorption, Distribution & Pharmacokinetics
Because Treclin is applied topically, systemic absorption is minimal. This ensures the therapeutic effect remains localised to the skin, reducing the risk of systemic side effects.
Clindamycin Absorption
After topical application, percutaneous absorption of clindamycin is extremely low (typically <0.5% of the applied dose). Peak plasma concentrations, if detectable, are less than 5 ng/mL and occur 2–4 hours after application.
Tretinoin Absorption
Percutaneous absorption of tretinoin from the gel formulation is also minimal (<2% of dose). Most of the applied tretinoin remains in the stratum corneum and pilosebaceous units, where it exerts its pharmacological effect. Systemic exposure is negligible.
Both agents show high skin binding; distribution is confined largely to the epidermis and dermis, with no significant accumulation in deep tissues.
Metabolic Effects & Elimination
Clindamycin: Any absorbed clindamycin is metabolised in the liver, primarily by CYP3A4, to inactive metabolites (clindamycin sulfoxide and N‑demethylclindamycin). The metabolites are excreted in urine and bile. Because absorption is negligible after topical use, hepatic metabolism plays a minor role.
Tretinoin: If absorbed, tretinoin undergoes oxidation by cytochrome P450 enzymes (CYP26 family, CYP3A4) to 4‑oxo‑ and 18‑hydroxy‑tretinoin, which are further conjugated and eliminated renally. However, the quantity absorbed is far below levels that would produce systemic effects.
⚠️ Metabolic caution: Patients with severe hepatic impairment should use Treclin only under medical supervision, though systemic exposure is negligible. No dosage adjustment is required in renal impairment.
Clinical Efficacy in Acne Treatment
Treclin is licensed for acne vulgaris in patients aged 12 years and older. In randomised controlled trials, once‑daily application at bedtime produced:
- ≥50% reduction in total lesion count after 12 weeks in 60–70% of patients.
- Significant reduction in inflammatory lesions (papules, pustules) as early as week 4.
- Superiority over either clindamycin or tretinoin alone for both inflammatory and non‑inflammatory lesions.
Patients often experience an initial “retinoid reaction” (mild erythema, dryness, peeling) during the first 2–3 weeks; this subsides with continued use. The full therapeutic benefit is typically seen after 8–12 weeks, and treatment may be continued for up to 12 weeks before re‑evaluation.
Treclin FAQs
How long does Treclin take to start working?
Most patients see initial improvement within 4–6 weeks. Full results (clear or near‑clear skin) usually require 8–12 weeks of consistent nightly application.
Can Treclin cause a flare‑up of acne initially?
Yes, tretinoin may cause an initial worsening (retinoid “purge”) during the first 2–3 weeks as deep comedones are brought to the surface. This is temporary and usually resolves with continued use.
What should I do if I experience severe diarrhoea while using Treclin?
Stop using Treclin immediately and contact your doctor. Although rare, clindamycin can cause antibiotic‑associated colitis even with topical use. Severe or persistent diarrhoea requires prompt medical evaluation.
Can I use Treclin if I am breastfeeding?
No. Treclin is not recommended during breastfeeding because it is not known whether its components pass into breast milk and could harm the baby. Consult your doctor for alternative treatments.
Does Treclin make skin sensitive to sunlight?
Yes, tretinoin increases photosensitivity. You must avoid sunbeds and prolonged sun exposure. Use a broad‑spectrum SPF 30+ sunscreen daily and wear protective clothing outdoors.
Need Treclin with Expert Guidance?
If you have moderate acne and believe a combination of clindamycin and tretinoin is right for you, a UK‑registered doctor can assess your suitability and provide a prescription online.
Secure Prescription & Next‑Day Delivery
MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors
Start Acne ConsultationRelated Treclin Guides
Medical Content Manager
Nabeel is a co‑founder and medical content manager at Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up‑to‑date.
Medical Doctor
Dr. Feroz is a GMC‑registered doctor and medical reviewer at Chemist Doctor. He oversees dermatology guidance and clinical accuracy.
Medical Director
Usman is a co‑founder and medical director of Chemist Doctor. He leads the organisation’s strategic vision, bridging clinical and operational priorities.
Review Date: 31 March 2026
Next Review: 30 September 2026
Published on: 31 March 2026
Last Updated: 31 March 2026